Publications by authors named "Andrew M Hirsch"

Claim this Profile
R
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
Grégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, Francis Couturaud, Carole Dennie, Andrew M Hirsch

Ann Intern Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery.
Adelina-Teona Avram, Mark D Blostein, Andrew M Hirsch, Theodore E Warkentin

Am J Hematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension.
Mateo Porres-Aguilar, Susan R Kahn, Andrew M Hirsch

J Thromb Haemost· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.
Kim A Ma, Susan R Kahn, Arash Akaberi, Carole Dennie, Christopher Rush, Andrew M Hirsch

Res Pract Thromb Haemost· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.
Susan R Kahn, Arash Akaberi, John T Granton, David R Anderson, Philip S Wells, Andrew M Hirsch

Am J Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study.
Susan R Kahn, Andrew M Hirsch, Arash Akaberi, Paul Hernandez, David R Anderson

Chest· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
Kim Ma, Susan R Kahn, Andrew M Hirsch, Arash Akaberi, David R Anderson

Thromb Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension.
Yang Zhan, Barry Burstein, Ali O Abualsaud, Mohamed Nosair, Andrew M Hirsch

Pulm Circ· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy as a possible trigger for heritable pulmonary arterial hypertension.
Maude Limoges, David Langleben, Benjamin D Fox, Roberta Shear, Paul Wieczorek, Andrew M Hirsch

Pulm Circ· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic.
Chantal Robitaille, Esther Dajczman, Andrew M Hirsch, David Small, Pierre Ernst

Can Respir J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension.
David Langleben, Stylianos E Orfanos, Michele Giovinazzo, Robert D Schlesinger, Andrew M Hirsch

Ann Intern Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated interdisciplinary care for patients with chronic obstructive pulmonary disease reduces emergency department visits, admissions and costs: a quality assurance study.
Esther Dajczman, Chantal Robitaille, Pierre Ernst, Andrew Michael Hirsch, Norman Wolkove

Can Respir J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
Benjamin Fox, David Langleben, Andrew M Hirsch, Robert D Schlesinger, Mark J Eisenberg

Can J Cardiol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.
Sanjay Mehta, Doug Helmersen, Steeve Provencher, Naushad Hirani, Fraser D Rubens, Andrew M Hirsch

Can Respir J· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial.
Susan R Kahn, Ian Shrier, Stan Shapiro, Adrielle H Houweling, Andrew M Hirsch

CMAJ· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension.
David Langleben, Jocelyn Dupuis, Isaac Langleben, Andrew M Hirsch, Murray Baron

Chest· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.
David Langleben, Stephen Archer, John Granton, Andrew M Hirsch, Robert D Levy

Can J Cardiol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.
David Langleben, Stephen Archer, John Granton, Andrew M Hirsch, Robert D Levy

Can Respir J· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study.
David Langleben, Andrew M Hirsch, Eileen Shalit, Lyda Lesenko, Robyn J Barst

Chest· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
David Langleben, Brian W Christman, Robyn J Barst, Virgil C Dias, Nazzareno Galiè, Andrew M Hirsch

Am Heart J· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis